Normothermic machine perfusion (NMP) to preserve livers prior to transplant was associated with significantly improved ...

Getinge will gradually phase out its surgical perfusion business, to focus on more profitable growth areas such as ECLS and ...

CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced Getinge off the U.S. market in 2015.

Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the ...

Getinge AB (GNGBF) reports robust sales growth and strategic restructuring amid market challenges and quality-related costs.

LivaNova (LIVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Matson from ...

Global Organ Preservation IndustryThe global organ preservation market is poised for steady expansion, with its value ...

Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...

Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions", says ...

Studies in mice show that microplastics entering the bloodstream are engulfed by immune cells, forming clusters that can ...

With a substantial 34% earnings before interest, taxes, and amortization beat in the fourth quarter, Getinge reported a ...